DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,202,000 | +16.2% | 8,527 | +14.1% | 0.14% | +16.8% |
| Q2 2022 | $1,895,000 | -9.2% | 7,475 | +5.1% | 0.12% | -15.6% |
| Q1 2022 | $2,086,000 | -21.2% | 7,113 | -11.6% | 0.14% | -17.5% |
| Q4 2021 | $2,648,000 | +14.5% | 8,048 | +5.9% | 0.17% | +6.2% |
| Q3 2021 | $2,313,000 | +25.4% | 7,598 | +10.6% | 0.16% | +21.1% |
| Q2 2021 | $1,844,000 | +20.6% | 6,870 | +1.2% | 0.13% | +8.1% |
| Q1 2021 | $1,529,000 | -3.3% | 6,791 | -4.6% | 0.12% | -6.1% |
| Q4 2020 | $1,581,000 | +12.8% | 7,115 | +9.2% | 0.13% | -1.5% |
| Q3 2020 | $1,402,000 | +35.7% | 6,513 | +11.5% | 0.13% | +15.7% |
| Q2 2020 | $1,033,000 | +17.0% | 5,843 | -8.4% | 0.12% | +3.6% |
| Q1 2020 | $883,000 | -13.8% | 6,379 | -4.4% | 0.11% | +1.8% |
| Q4 2019 | $1,024,000 | -0.5% | 6,675 | -6.3% | 0.11% | -8.4% |
| Q3 2019 | $1,029,000 | -2.3% | 7,127 | -3.3% | 0.12% | -3.3% |
| Q2 2019 | $1,053,000 | +30.6% | 7,371 | +20.8% | 0.12% | +26.8% |
| Q1 2019 | $806,000 | +26.5% | 6,104 | -1.3% | 0.10% | +21.2% |
| Q4 2018 | $637,000 | -1.1% | 6,182 | +4.3% | 0.08% | +11.1% |
| Q3 2018 | $644,000 | +10.7% | 5,926 | +0.4% | 0.07% | -14.3% |
| Q2 2018 | $582,000 | +6.6% | 5,902 | +5.9% | 0.08% | +1.2% |
| Q1 2018 | $546,000 | +11.7% | 5,574 | +5.7% | 0.08% | +15.3% |
| Q4 2017 | $489,000 | +8.2% | 5,273 | 0.0% | 0.07% | +1.4% |
| Q3 2017 | $452,000 | -1.1% | 5,273 | -2.7% | 0.07% | -4.1% |
| Q2 2017 | $457,000 | -0.4% | 5,417 | +1.0% | 0.07% | -5.1% |
| Q1 2017 | $459,000 | +20.5% | 5,364 | +9.7% | 0.08% | +20.0% |
| Q4 2016 | $381,000 | +3.8% | 4,889 | +4.5% | 0.06% | -3.0% |
| Q3 2016 | $367,000 | -23.9% | 4,678 | -2.0% | 0.07% | -22.1% |
| Q2 2016 | $482,000 | +52.5% | 4,772 | +43.2% | 0.09% | +53.6% |
| Q1 2016 | $316,000 | +3.3% | 3,332 | +1.1% | 0.06% | +9.8% |
| Q4 2015 | $306,000 | +8.9% | 3,296 | 0.0% | 0.05% | +2.0% |
| Q3 2015 | $281,000 | -1.7% | 3,296 | -1.5% | 0.05% | +6.4% |
| Q2 2015 | $286,000 | -5.6% | 3,346 | -6.1% | 0.05% | +9.3% |
| Q1 2015 | $303,000 | -12.2% | 3,565 | -11.5% | 0.04% | -14.0% |
| Q4 2014 | $345,000 | +11.3% | 4,029 | -1.3% | 0.05% | +6.4% |
| Q3 2014 | $310,000 | -5.2% | 4,082 | -1.8% | 0.05% | +23.7% |
| Q2 2014 | $327,000 | -1.5% | 4,155 | -6.1% | 0.04% | -7.3% |
| Q1 2014 | $332,000 | +19.0% | 4,425 | +22.5% | 0.04% | +7.9% |
| Q4 2013 | $279,000 | +6.5% | 3,611 | -4.5% | 0.04% | -13.6% |
| Q3 2013 | $262,000 | +17.5% | 3,780 | +7.4% | 0.04% | +10.0% |
| Q2 2013 | $223,000 | – | 3,521 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |